Quantcast

Latest proteinuria Stories

2014-09-11 08:28:06

CAMBRIDGE, Mass., Sept. 11, 2014 /PRNewswire-USNewswire/ -- Claritas Genomics, a clinical laboratory serving the DNA-based diagnostic testing needs of children's hospitals, announced the availability of a next-generation sequencing assay that investigates 28 genes that represent single-gene causes of pediatric steroid-resistant Nephrotic Syndrome. The assay was developed in collaboration with a laboratory at Boston Children's Hospital that has been studying the underlying genetic...

2014-07-28 20:24:33

HAYWARD, Calif., July 28, 2014 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), today announced financial results and operational update for the second quarter ended June 30, 2014. Net loss for the three months ended June 30, 2014 was $7.3 million, compared to $8.3 million for the same period in 2013. The decrease in net loss is a direct result of a decrease in interest expense in the current period. Net loss for the six months ended June 30, 2014 was $15.2 million,...

2014-06-06 10:04:08

Joslin Diabetes Center People with type 1 diabetes who have developed kidney complications can slow the progression of their complications by improving control of their glycemic (blood glucose) levels over the long term. This finding, which may change clinical practice at many institutions for this population, was drawn from a long-term observational study led by Andrzej Krolewski, M.D., Ph.D., head of Joslin Diabetes Center's Section on Genetics and Epidemiology. Running for almost...

2014-05-13 08:33:02

HAYWARD, Calif., May 13, 2014 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), today announced financial results and operational update for the first quarter ended March 31, 2014. First Quarter 2014 Financial Results: Net loss for the first quarter ended March 31, 2014 was $7.9 million, compared to $7.6 million for the same period in 2013. Operating expenses for the three months ended March 31, 2014 increased to $7.6 million from $6.9 million in the same period of...

2014-04-21 08:26:07

- Clinical results appear to correlate with reduction in anti-PLA2R antibodies ANAHEIM, Calif., April 21, 2014 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) today announced that results from an investigator-initiated clinical study involving two major academic research centers examining the dosing and effectiveness of H.P. Acthar® Gel (repository corticotropin) in 20 patients with nephrotic syndrome due to idiopathic membranous nephropathy (iMN) have been published in the...

Soda Consumption May Damage Kidneys
2013-11-11 04:33:03

Alan McStravick for redOrbit.com - Your Universe Online The subject of late night comedian’s derision for several months, Mayor Michael Bloomberg’s New York City-wide ban on large sodas met an untimely end in March of this year, just days before it was to have gone into effect. The UK is proposing a tax increase of 20 percent on sodas, claiming the move will stem the tide of heaviness in their country by as many as 285,000 of their citizens. Additionally, they believe they will...

2013-09-23 23:34:17

Although Acthar Gel has numerous indications and data suggest that it may be a viable treatment option for resistant nephrotic syndrome, there remains a lack of guidelines on its use. Portland, OR (PRWEB) September 23, 2013 During a recent webinar hosted by AllMed Healthcare Management, Dr. James Wood, board-certified internist and nephrologist, gave an in-depth presentation on the use of Acthar Gel for the treatment of nephrotic syndrome. Although Acthar Gel has numerous indications and...


Word of the Day
caparison
  • A cloth or covering, more or less ornamented, laid over the saddle or furniture of a horse, especially of a sumpter-horse or horse of state.
  • Clothing, especially sumptuous clothing; equipment; outfit.
  • To cover with a caparison, as a horse.
  • To dress sumptuously; adorn with rich dress.
This word ultimately comes from the Medieval Latin 'cappa,' cloak.
Related